Predictors of anti-TNF treatment failure in anti-TNF-naive
4.5
$ 14.50
In stock
(715)
Product Description
Abdullah Abbasi on X: Excited to share review of this article in @southasianIBD and @IbdClub. Study: Authors include @DrNickKennedy, @ibdseb and others. Format: Brief 5-6 mins video followed by discussion on
Mistakes in therapeutic drug monitoring of biologics in IBD and how to avoid them
Tumour necrosis factor inhibitors in inflammatory bowel disease: the story continues - Laurent Peyrin-Biroulet, William J. Sandborn, Remo Panaccione, Eugeni Domènech, Lieven Pouillon, Britta Siegmund, Silvio Danese, Subrata Ghosh, 2021
Flowchart of adalimumab outcomes in anti-TNF-naïve and
Tumor necrosis factor–like cytokine 1A plays a role in inflammatory bowel disease pathogenesis
Serum albumin is the strongest predictor of anti-tumor necrosis factor nonresponse in inflammatory bowel disease in resource-constrained regions lacking therapeutic drug monitoring
Predictors of anti-TNF failure in Crohn
Frontiers What Is the Clinical Relevance of TNF Inhibitor Immunogenicity in the Management of Patients With Rheumatoid Arthritis?
Treatment of anemia in difficult-to-manage patients with chronic kidney disease - Kidney International Supplements
Molecular mechanism of action of anti-tumor necrosis factor antibodies in inflammatory bowel diseases
Paradoxical Reactions to Anti-TNFα and Anti-IL-17 Treatment in Psoriasis Patients: Are Skin and/or Gut Microbiota Involved?
